Wildman MJ - Search Results

1

Predicting mortality for patients with exacerbations of COPD and Asthma in the COPD and Asthma Outcome Study (CAOS).

Wildman MJ, Sanderson C, Groves J, Reeves BC, Ayres J, Harrison D, Young D, Rowan K. Wildman MJ, et al. QJM. 2009 Jun;102(6):389-99. doi: 10.1093/qjmed/hcp036. Epub 2009 Apr 15. QJM. 2009. PMID: 19369483

2

"I think most people feel like healthcare professionals tell them to take their treatments and judge them for not taking them": reflexive thematic analysis of the views of adults with cystic fibrosis on how treatment adherence is discussed in healthcare.

Dawson S, Rodham K, Taylor J, Dewar J, Wildman M. Dawson S, et al. Psychol Health. 2023 Sep 4:1-23. doi: 10.1080/08870446.2023.2254318. Online ahead of print. Psychol Health. 2023. PMID: 37667520

3

Future Discounting Bias and Scenarios Without Lock-Step FEV₁/Life Expectancy Coherence May Result in Suboptimal Treatment Recommendations.

Hoo ZH, Dawson S, Daniels TE, Lai LY, Hutchings M, Wildman MJ. Hoo ZH, et al. Among authors: wildman mj. Chest. 2023 Apr;163(4):e193-e194. doi: 10.1016/j.chest.2022.11.046. Chest. 2023. PMID: 37031993 No abstract available.

4

Regarding the article entitled "Effect of elexacaftor/tezacaftor/ivacaftor on annual rate of lung function decline in people with cystic fibrosis".

Hoo ZH, Lai LY, Sandler RD, Daniels TE, Dawson S, Hutchings M, Wildman MJ. Hoo ZH, et al. Among authors: wildman mj. J Cyst Fibros. 2023 May;22(3):587. doi: 10.1016/j.jcf.2023.03.012. Epub 2023 Mar 21. J Cyst Fibros. 2023. PMID: 36948912 No abstract available.

5

Development of data processing algorithm to calculate adherence for adults with cystic fibrosis using inhaled therapy - a multi-center observational study within the CFHealthHub learning health system.

Sandler RD, Lai L, Dawson S, Cameron S, Lynam A, Sperrin M, Hoo ZH, Wildman MJ. Sandler RD, et al. Among authors: wildman mj. Expert Rev Pharmacoecon Outcomes Res. 2024 Jul;24(6):759-771. doi: 10.1080/14737167.2024.2328085. Epub 2024 Mar 12. Expert Rev Pharmacoecon Outcomes Res. 2024. PMID: 38458615

6

Long term vascular complications of Coxiella burnetii infection. Cardiovascular risk factors cannot be ignored.

Wildman M, Ayres JG. Wildman M, et al. BMJ. 2000 Jan 1;320(7226):58-9. BMJ. 2000. PMID: 10617545 Free PMC article. No abstract available.

7

Chronic fatigue following infection by Coxiella burnetii (Q fever): ten-year follow-up of the 1989 UK outbreak cohort.

Wildman MJ, Smith EG, Groves J, Beattie JM, Caul EO, Ayres JG. Wildman MJ, et al. QJM. 2002 Aug;95(8):527-38. doi: 10.1093/qjmed/95.8.527. QJM. 2002. PMID: 12145392

8

Long-term follow-up of patients from the 1989 Q fever outbreak: no evidence of excess cardiac disease in those with fatigue.

Ayres JG, Wildman M, Groves J, Ment J, Smith EG, Beattie JM. Ayres JG, et al. QJM. 2002 Aug;95(8):539-46. doi: 10.1093/qjmed/95.8.539. QJM. 2002. PMID: 12145393

9

Q fever: still a mysterious disease.

Wildman MJ, Ayres JG. Wildman MJ, et al. QJM. 2002 Dec;95(12):833-4. doi: 10.1093/qjmed/95.12.833. QJM. 2002. PMID: 12524714 No abstract available.

10

Variation in intubation decisions for patients with chronic obstructive pulmonary disease in one critical care network.

Wildman MJ, O'Dea J, Kostopoulou O, Tindall M, Walia S, Khan Z. Wildman MJ, et al. QJM. 2003 Aug;96(8):583-91. doi: 10.1093/qjmed/hcg104. QJM. 2003. PMID: 12897344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters